What is levodopa inhalation powder mist (Inbrija)? Is it available in China?

Levodopa inhalation powder is a drug used to treat Parkinson's disease and its related symptoms. Its main ingredients are a combination of levodopa and carbidopa. Parkinson's disease is a chronic neurological disorder characterized by symptoms such as tremors, muscle stiffness, and slowed movements, often caused by insufficient dopamine levels in the brain. Dopamine is an important neurotransmitter responsible for regulating movement and controlling muscle activity. Levodopa inhalation powder helps relieve these symptoms by replenishing dopamine in the brain.

Levodopa is a central nervous system drug whose mechanism of action is to convert into dopamine after entering the brain, thereby making up for the lack of dopamine in the brains of patients with Parkinson's disease. However, levodopa is easily broken down by enzymes in the body before it enters the brain, resulting in a weakened effect. To overcome this problem, levodopa is often combined with carbidopa. Carbidopa is a decarboxylase inhibitor that prevents levodopa from being broken down before entering the brain, thereby increasing the utilization of levodopa. This combination not only enhances the effectiveness of the drug, but also reduces the dosage requirement of levodopa, thereby reducing the incidence of side effects such as nausea and vomiting.

Levodopa inhalation powder is administered through inhalation, which can quickly deliver the drug to the lungs, where it can quickly enter the blood circulation and reach the brain. This method of administration is particularly suitable for patients who have difficulty swallowing or gastrointestinal malabsorption when taking oral medications. In addition, the inhalation powder form can also provide a faster onset of action, helping patients relieve symptoms in a short period of time.

In addition to being used to treat Parkinson's disease, levodopa inhalation powder can also be used to treat Parkinson's disease-like symptoms caused by encephalitis, carbon monoxide poisoning, or manganese poisoning. These conditions can cause dopamine levels to drop in the brain, causing movement disorders similar to Parkinson's disease. By supplementing dopamine, levodopa inhalation powder can effectively improve these symptoms and improve the patient's quality of life.

However, despite the significant effectiveness of levodopa inhalation powder in the treatment of Parkinson's disease and its related symptoms, patients still need to be aware of possible side effects during use. Common side effects include nausea, vomiting, dizziness and low blood pressure. Long-term use of levodopa may also lead to complications such as movement fluctuations and dyskinesias. Therefore, patients should strictly follow the doctor's instructions when using it, and conduct regular condition evaluation and medication adjustments.

Overall, levodopa inhalation powder, as an innovative delivery form, provides a fast and effective treatment option for patients with Parkinson's disease. Through the synergistic effect of levodopa and carbidopa, the drug can significantly improve patients' motor functions, reduce symptoms, and improve quality of life. However, patients should pay close attention to possible side effects during use and use the medication rationally under the guidance of a doctor.

Currently, levodopa inhalation powder is not available in China, and domestic patients have no way to purchase it directly from hospitals. It is understood that the levodopa inhalation powder spray version has been launched overseas again. The specification is 33mg*60 tablets and the price is about 6,000. If the patient needs levodopa inhalation powder, please consult an overseas medical consultant.

Reference link:https://medlineplus.gov/druginfo/meds/a619018.html